Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer

被引:29
作者
Bardi, G
Parada, LA
Bomme, L
Pandis, N
Willen, R
Johansson, B
Jeppsson, B
Beroukas, K
Heim, S
Mitelman, F
机构
[1] UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN
[2] ODENSE UNIV,DEPT MED GENET,ODENSE,DENMARK
[3] UNIV LUND HOSP,DEPT PATHOL,S-22185 LUND,SWEDEN
[4] UNIV LUND HOSP,DEPT SURG,S-22185 LUND,SWEDEN
[5] INST SOCIAL INSURANCE,ONCOL RADIOTHERAPY CTR,ATHENS,GREECE
[6] NORWEGIAN RADIUM HOSP,DEPT GENET,OSLO,NORWAY
[7] INST CANC RES,N-0310 OSLO,NORWAY
关键词
cytogenetics; karyotype; chromosome; cancer; colorectal carcinoma; polyp;
D O I
10.1038/bjc.1997.459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thirty tumorous lesions from seven patients with colorectal cancer were short-term cultured and cytogenetically analysed: 16 non-adenomatous polyps, six adenomas, seven carcinomas, including one in polyp, and one lymph node metastasis. Clonal chromosome aberrations were found in 20 samples in 100% of the carcinomas, in 100% of the adenomas and in 37.5% of the non-adenomatous polyps, i.e. all ten lesions with a normal karyotype were histologically diagnosed as hyperplastic polyps. Although adenomas and carcinomas shared several karyotypic features, two chromosome aberrations, der(8;17)(q10;q10) and -14, were found in carcinomas but not in adenomas, indicating that they might be specifically associated with carcinoma development in the large bowel mucosa. The karyotypic similarity seen between the malignant and benign tumours in the same patient, and also sometimes among non-malignant polyps in the same case, indicates that these microscopically distinct lesions may be part of a single neoplastic clonal expansion.
引用
收藏
页码:765 / 769
页数:5
相关论文
共 18 条
[1]  
BARDI G, 1993, CANCER RES, V53, P1895
[2]   KARYOTYPIC CHARACTERIZATION OF COLORECTAL ADENOCARCINOMAS [J].
BARDI, G ;
SUKHIKH, T ;
PANDIS, N ;
FENGER, C ;
KRONBORG, O ;
HEIM, S .
GENES CHROMOSOMES & CANCER, 1995, 12 (02) :97-109
[3]  
BARDI G, 1997, IN PRESS CYTOGENETIC
[4]  
BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO
[5]  
2-B
[6]  
FEARON ER, 1994, ADV INTERNAL MED, V39, P123
[7]  
FENOGLIOPREISER CM, 1988, BASIC CLIN PERSPECTI, P3
[8]  
Heim S, 1995, CANC CYTOGENETICS, P325
[9]  
JASS IR, 1987, ALIMENTARY TRACT, P313
[10]  
JASS JR, 1984, CANCER-AM CANCER SOC, V53, P510, DOI 10.1002/1097-0142(19840201)53:3<510::AID-CNCR2820530324>3.0.CO